Related Experiment Video
Updated: Jun 6, 2025

Isolation and Quantification of Epstein-Barr Virus from the P3HR1 Cell Line
Published on: September 28, 2022
Epstein-Barr Virus-Positive Diffuse Large B-cell Lymphoma Arising in Ulcerative Colitis: An Instructive Case Report
Yuichiro Hamamoto1, Saori Matsui2, Kiyotaka Okawa2
1Diagnostic Pathology, Osaka International Medical & Science Center, Osaka, JPN.
Malignant lymphoma is a rare ulcerative colitis (UC) complication. This case highlights diagnostic challenges of Epstein-Barr virus-positive diffuse large B-cell lymphoma in elderly UC patients on immunosuppressants.
Area of Science:
- Gastroenterology and Oncology
- Immunology
Background:
- Ulcerative colitis (UC) patients have a slightly increased risk of developing malignant lymphoma.
- The etiology of lymphoma in UC is not fully understood, but immunosuppression is a potential factor.
Observation:
- A challenging case of Epstein-Barr virus-positive diffuse large B-cell lymphoma (EBV+ DLBCL) in an elderly patient with a history of UC.
- The patient was treated with tacrolimus, an immunomodulator, and indigo naturalis herbal medicine.
Findings:
- The lymphoma presented diagnostic difficulties due to macroscopic similarities with inflammatory bowel disease complications.
- Epstein-Barr virus positivity was noted in the diffuse large B-cell lymphoma.
Implications:
- This case underscores the importance of vigilant surveillance for lymphoma in UC patients, especially those on immunosuppressive therapy.
- Early and accurate diagnosis of lymphoma in UC patients is crucial for appropriate management and improved outcomes.
More Related Videos
09:43An Efficient and Simple Method to Establish NK and T Cell Lines from Patients with Chronic Active Epstein-Barr Virus Infection
Published on: March 30, 2018
08:44Separation of Immune Cell Subpopulations in Peripheral Blood Samples from Children with Infectious Mononucleosis
Published on: September 7, 2022
Related Concept Videos
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...